B4GALNT3 Antibody

Product Specifications

Background

B4GALNT3 transfers N-acetylgalactosamine (GalNAc) onto glucosyl residues to form N, N-prime-diacetyllactosediamine (LacdiNAc, or LDN), a unique terminal structure of cell surface N-glycans (Ikehara et al., 2006 [PubMed 16728562]) .[supplied by OMIM].

NCBI Gene ID

283358

Swiss Prot

Q6L9W6

Accession Number

Q6L9W6

Host

Rabbit

Reactivity

Human

Immunogen

This B4GALNT3 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 555-584 amino acids from the Central region of human B4GALNT3.

Clonality

Polyclonal

Conjugation

Unconjugated

Type

Primary Antibodies

Field of Research

Other

Purification

This antibody is purified through a protein A column, followed by peptide affinity purification.

Concentration

Batch dependent

Buffer

Supplied in PBS with 0.09% (W/V) sodium azide.

Modification

None

Shipping Conditions

Blue Ice

Storage Conditions

Store at 4˚ C for three months and -20˚ C, stable for up to one year. As with all antibodies care should be taken to avoid repeated freeze thaw cycles. Antibodies should not be exposed to prolonged high temperatures.

Calculated Molecular Weight

115 kDa

Fragment

Rabbit Ig

Symbol

B4GALNT3

NCBI Official Name

Beta-1,4-N-acetylgalactosaminyltransferase 3

NCBI Organism

Homo sapiens

Background Reference 01

Rose, J. Phd, et al. Mol. Med. (2010) In press :

Background Reference 02

Arking, D.E., et al. PLoS ONE (3), E9879 (2010) :

Background Reference 03

Miller, E., et al. J. Biol. Chem. 283 (4) :1985-1991 (2008)

Background Reference 04

Huang, J., et al. Mol. Cancer Res. 5 (6) :543-552 (2007)

Other Product Names

Beta-1,4-N-acetylgalactosaminyltransferase 3, B4GalNAcT3, Beta4GalNAc-T3, Beta4GalNAcT3, Beta-1,4-N-acetylgalactosaminyltransferase III, N-acetyl-beta-glucosaminyl-glycoprotein 4-beta-N-acetylgalactosaminyltransferase 2, NGalNAc-T2, B4GALNT3